Zhejiang Hisun Pharmaceutical Co.,Ltd.’s Net Profit Rose 39.8% in First Three Quarters of 2023

Zhejiang Hisun Pharmaceutical Co.,Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 472.9 million yuan in the first three quarters of 2023, up 39.8% year-on-year.

Meanwhile, the company posted 8.7 billion yuan in revenue, down 0.5% year-on-year.

At the end of the reporting period, it had 18.1 billion yuan in total assets and 9.3 billion yuan in total liabilities, with a liability-to-asset ratio of 51.2%.